Reginald F. Frye

Effect of St John's wort on imatinib mesylate pharmacokinetics

Reginald F. Frye, Sara M. Fitzgerald, Theodore Lagattuta et al. · Clinical Pharmacology & Therapeutics · 2004 · 254 citations

Liver disease selectively modulates cytochrome P450–mediated metabolism

Reginald F. Frye, N ZGHEIB, Gary R. Matzke et al. · Clinical Pharmacology & Therapeutics · 2006 · 242 citations

Validation of the five-drug “Pittsburgh cocktail” approach for assessment of selective regulation of drug-metabolizing enzymes*

Reginald F. Frye, Gary R. Matzke, Adedayo Adedoyin et al. · Clinical Pharmacology & Therapeutics · 1997 · 241 citations

INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN’S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES

Bernard J. Komoroski, Shimin Zhang, Hongbo Cai et al. · Drug Metabolism and Disposition · 2004 · 180 citations

Effects of high-fructose corn syrup and sucrose on the pharmacokinetics of fructose and acute metabolic and hemodynamic responses in healthy subjects

MyPhuong T. Le, Reginald F. Frye, Christopher J. Rivard et al. · Metabolism · 2011 · 163 citations · Full text

Metabolic Syndrome, Nutrition, Healthy Subjects +8